Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Sigyn Therapeutics Total Liabilities (Quarterly): 3.734M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.734M |
| September 30, 2023 | 3.963M |
| June 30, 2023 | 3.404M |
| March 31, 2023 | 3.006M |
| December 31, 2022 | 2.236M |
| September 30, 2022 | 2.104M |
| June 30, 2022 | 1.579M |
| March 31, 2022 | 1.179M |
| December 31, 2021 | 0.9748M |
| September 30, 2021 | 1.083M |
| June 30, 2021 | 1.015M |
| March 31, 2021 | 0.6892M |
| December 31, 2020 | 0.5949M |
| September 30, 2020 | 3.430M |
| June 30, 2020 | 3.292M |
| March 31, 2020 | 3.203M |
| December 31, 2019 | 3.103M |
| September 30, 2019 | 4.680M |
| Date | Value |
|---|---|
| June 30, 2019 | 4.577M |
| March 31, 2019 | 4.487M |
| December 31, 2018 | 4.577M |
| September 30, 2018 | 4.549M |
| June 30, 2018 | 4.397M |
| March 31, 2018 | 4.446M |
| December 31, 2017 | 4.165M |
| September 30, 2017 | 5.117M |
| June 30, 2017 | 3.938M |
| March 31, 2017 | 3.424M |
| December 31, 2016 | 3.034M |
| September 30, 2016 | 2.300M |
| June 30, 2016 | 2.133M |
| March 31, 2016 | 1.709M |
| December 31, 2015 | 1.426M |
| September 30, 2015 | 0.8589M |
| December 31, 2014 | 0.4628M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.5949M
Minimum
Dec 2020
4.680M
Maximum
Sep 2019
2.518M
Average
3.006M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3218M |
| Shareholders Equity (Quarterly) | -3.412M |